The latest closing stock price for Xilio Therapeutics as of July 22, 2025 is 0.70.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-956 today, roughly -1 times their original investment - a -54.27% compound annual growth rate over 4 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 1.70, which is 142.9% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.62, which is 11.4% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 0.86.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-956 today, roughly -1 times their original investment - a -54.27% compound annual growth rate over 4 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 1.70, which is 142.9% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.62, which is 11.4% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 0.86.